Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015;1(2):116-122.
doi: 10.1016/S2055-6640(20)30482-9. Epub 2015 Apr 1.

Markers of HIV reservoir size and immune activation after treatment in acute HIV infection with and without raltegravir and maraviroc intensification

Affiliations

Markers of HIV reservoir size and immune activation after treatment in acute HIV infection with and without raltegravir and maraviroc intensification

Jintanat Ananworanich et al. J Virus Erad. 2015.

Abstract

Background: It is unclear whether intensification of standard highly active antiretroviral therapy (HAART) with entry and integrase inhibitors during acute HIV infection (AHI) could yield greater benefits in reducing markers for HIV reservoir size and immune activation.

Methods: Thai patients with Fiebig I-IV AHI were prospectively enrolled and offered treatment. They were randomised 1:1 to HAART (tenofovir/emtricitabine/efavirenz, n =31) or megaHAART, a standard regimen intensified by raltegravir/maraviroc (n =31), during the first 24 weeks of therapy. Participants were monitored at weeks 0, 2, 4, 8 and 12, then every 12 weeks. Frequencies of peripheral blood mononuclear cells (PBMCs) carrying HIV DNA (total, integrated and 2-LTR episomes), plasma C-reactive protein (CRP) concentrations, and frequencies of activated T cells were measured. Flexible sigmoidoscopy was performed in willing participants (n =25) at baseline, weeks 24 and 96, and proviral DNA and RNA were determined.

Results: Baseline characteristics were similar in the HAART and megaHAART arms. Median age was 28 years and 95% were men. Median CD4 cell count was 388 cells/mm3. HIV RNA was 5.6 log10 copies/mL. HIV RNA declined more rapidly in the first 4 weeks with megaHAART (median -3.3 log10) than HAART (-2.6 log10). Time to achieve HIV RNA <50 copies/mL was shorter with megaHAART (median 55 days) than HAART (83 days, P =0.04). Viral suppression rates after week 12 did not differ between arms, and overall, 97% achieved suppression by week 48. The frequency of cells harbouring total HIV DNA was similarly low after 96 weeks in both treatment arms (median of 7 and 4 copies/106 PBMCs in the megaHAART and HAART arms, respectively, P =0.41). At weeks 2 and 12, frequency of cells carrying 2-LTR circles were significantly higher with megaHAART (P =0.03). In the sigmoid colon, total HIV DNA and HIV RNA declined after treatment, with no differences between arms. The frequencies of cells with 2-LTR circles were also higher in the sigmoid colon at week 24 with megaHAART. Plasma levels of CRP and frequencies of CD4+ and CD8+ T cells expressing CD38 and HLA-DR or Ki67 were similar between arms.

Conclusions: Intensification of standard HAART with raltegravir and maraviroc was not associated with either statistically significant reductions of markers of HIV reservoir size in blood and sigmoid colon or markers of immune activation in blood.

Keywords: ART; Acute HIV infection; HIV DNA; immune activation; maraviroc; raltegravir; reservoir.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Study screening and accrual *Three megaHAART patients missed their week 96 visit
Figure 2.
Figure 2.
Median (a) plasma HIV RNA and (b) CD4 T cell counts after megaHAART or HAART initiated in acute HIV infection (P value <0.05).
Figure 3.
Figure 3.
Total (a) HIV DNA and (b) 2-LTR circles in peripheral blood mononuclear cells after megaHAART or HAART in acute HIV infection (P value <0.05)
Figure 4.
Figure 4.
Total HIV DNA in sigmoid colon after megaHAART or HAART in acute HIV infection
Figure 5.
Figure 5.
Median levels of plasma CRP after megaHAART or HAART in acute HIV infection
Figure 6.
Figure 6.
Frequencies of activated CD8+ T cells (CD38+ and HLA-DR+) after megaHAART or HAART in acute HIV infection

Similar articles

Cited by

References

    1. Chomont N, El-Far M, Ancuta P et al. . HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 2009; 15: 893– 900. - PMC - PubMed
    1. Chun TW, Engel D, Berrey MM et al. . Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proc Natl Acad Sci U S A 1998; 95: 8869– 8873. - PMC - PubMed
    1. Ananworanich J, Schuetz A, Vandergeeten C et al. . Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection. PLoS One 2012; 7: e33948. - PMC - PubMed
    1. Archin NM, Vaidya NK, Kuruc JD et al. . Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection. Proc Natl Acad Sci U S A 2012; 109: 9523– 9528. - PMC - PubMed
    1. Josefsson L, Stockenstrom S, Faria NR et al. . The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time. Proc Natl Acad Sci U S A 2013; 110: E4987– 4996. - PMC - PubMed

LinkOut - more resources